Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

RING - Rituximab for Lupus Nephritis With Remission as a Goal, an Investigator-initiated Randomized International Open Multicentric Study

NCT01673295 is registered in ClinicalTrials.gov with Frédéric A. Houssiau, MD, PhD as lead sponsor.

NCT NCT01673295
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01673295 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
RING - Rituximab for Lupus Nephritis With Remission as a Goal, an Investigator-initiated Randomized International Open Multicentric Study
Lead sponsor
Frédéric A. Houssiau, MD, PhD
Phase
Phase 3
Overall status
Unknown status
Start date
November 30, 2014
Completion date
November 30, 2016
Enrollment
194 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lupus nephritis